S-Caine™ Peel (Skin Numbing Cream) to Treat Pain During Laser-Assisted Tattoo Removal in Adults
A Randomized, Double-Blind, Placebo Controlled, Paired Study Evaluating S-Caine™ Peel (Lidocaine 7% and Tetracaine 7% Cream) for Induction of Local Dermal Anesthesia for Laser-Assisted Tattoo Removal in Adults
1 other identifier
interventional
60
1 country
1
Brief Summary
There is pain associated with laser-assisted tattoo removal. For this reason, some form of anesthesia is commonly used to eliminate or minimize the pain. This anesthesia is usually a topical local anesthetic cream or ointment spread over the skin. The purpose of this study is to further estimate the effectiveness of S-Caine™ Peel (lidocaine 7% and tetracaine 7% cream) for treating pain during laser-assisted tattoo removal.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for phase_3 pain
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 12, 2005
CompletedFirst Posted
Study publicly available on registry
May 13, 2005
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2005
CompletedSeptember 23, 2005
September 1, 2005
May 12, 2005
September 21, 2005
Conditions
Outcome Measures
Primary Outcomes (1)
To evaluate the efficacy of S-Caine Peel when applied for 60 minutes for induction of local dermal anesthesia prior to laser-assisted tattoo removal in adults
Secondary Outcomes (1)
To monitor the nature and frequency of adverse events (AEs) associated with the application of S-Caine Peel
Interventions
Eligibility Criteria
You may qualify if:
- Patient is 18 years of age or older
- Patient elects to undergo laser-assisted tattoo removal
You may not qualify if:
- Patient is pregnant or breastfeeding
- Patient has participated in a clinical trial of an unapproved drug within the previous 30 days
- Patient has participated in any previous clinical trial involving S-Caine Peel
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- ZARS Pharma Inc.lead
Study Sites (1)
Laser and Skin Surgery Center of New York
New York, New York, 10016, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Purpose
- TREATMENT
- Sponsor Type
- INDUSTRY
Study Record Dates
First Submitted
May 12, 2005
First Posted
May 13, 2005
Study Completion
September 1, 2005
Last Updated
September 23, 2005
Record last verified: 2005-09